Development of 68Ga-Labeled Hepatitis E Virus Nanoparticles for Targeted Drug Delivery and Diagnostics with PET
Targeted delivery of diagnostics and therapeutics offers essential advantages over nontargeted systemic delivery. These include the reduction of toxicity, the ability to reach sites beyond biological barriers, and the delivery of higher cargo concentrations to diseased sites. Virus-like particles (V...
Saved in:
Published in | Molecular pharmaceutics Vol. 19; no. 8; pp. 2971 - 2979 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
American Chemical Society
01.08.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!